We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Nanoparticles Designed to Deliver Drugs to Targeted Cells

By LabMedica International staff writers
Posted on 16 Jul 2014
Print article
Image: The nanoparticles, which are capable of delivering and exchanging complementary molecules, emit a fluorescent signal that can be observed with a microscope (Photo courtesy of the University of Miami).
Image: The nanoparticles, which are capable of delivering and exchanging complementary molecules, emit a fluorescent signal that can be observed with a microscope (Photo courtesy of the University of Miami).
Investigators are exploring the use and behavior of nanoparticles to deliver molecules to target cells.

There is a great demand for the development of nanoparticles that can transport and deliver drugs to target cells in the human body. Researchers from the University of Miami (UM; Coral Gables, USA) have created nanoparticles that, under favorable settings, can self-assemble, ensnaring complementary guest molecules within their structure. These adaptable nanocarriers can travel in the aqueous environment encircling cells and transport their passenger molecules through the membrane of living cells to sequentially deliver their payload.

Although the transport of molecules inside cells with nanoparticles has been earlier achieved using various methods, researchers have developed nanoparticles capable of delivering and exchanging complementary molecules. For practical applications, these nanocarriers are highly desirable, reported Francisco Raymo, professor of chemistry in the University of Miami College of Arts and Sciences and lead investigator of the project. “The ability to deliver distinct species inside cells independently and force them to interact, exclusively in the intracellular environment, can evolve into a valuable strategy to activate drugs inside cells,” said Prof. Raymo.

The new nanocarriers are 15 nm in diameter. They are supramolecular constructs comprised of amphiphilic polymers. These nanocarriers hold the guest molecules within the boundaries of their water-insoluble core and use their water-soluble exterior to move through an aqueous environment. As a result, these nanovehicles are is suitable for transferring molecules, which would otherwise be insoluble in water, across a liquid environment.

“Once inside a living cell, the particles mix and exchange their cargo. This interaction enables the energy transfer between the internalized molecules,” said Prof. Raymo, director of UM’s laboratory for molecular photonics. “If the complementary energy donors and acceptors are loaded separately and sequentially, the transfer of energy between them occurs exclusively within the intracellular space. As the energy transfer takes place, the acceptors emit a fluorescent signal that can be observed with a microscope.”

Crucial for this process are the noncovalent bonds that loosely hold the supramolecular constructs together. These weak bonds exist between molecules with complementary shapes and electronic characteristics. They are responsible for the ability of supramolecules to assemble spontaneously in liquid environments. Under the right conditions, the reversibility of these weak noncovalent contacts allows the supramolecular constructs to exchange their components as well as their cargo.

The research was conducted with cell cultures. It is not yet known if the nanoparticles can actually travel through the bloodstream. “That would be the dream, but we have no evidence that they can actually do so,” said Prof. Raymo. “However, this is the direction we are heading.”

The next step of this study involves demonstrating that this method can be used to do chemical reactions inside cells, instead of energy transfers. “The size of these nanoparticles, their dynamic character, and the fact that the reactions take place under normal biological conditions [at ambient temperature and neutral environment] makes these nanoparticles an ideal vehicle for the controlled activation of therapeutics directly inside the cells,” Prof. Raymo concluded.

The study’s findings were published in the Journal of the American Chemical Society.

Related Links:

University of Miami


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.